• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Odontogenic Tumor Companies

    ID: MRFR/MED/4920-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Odontogenic tumor companies specialize in addressing tumors that originate from the tissues involved in tooth development. These companies contribute to oral and maxillofacial pathology by providing diagnostic tools, imaging technologies, and treatment solutions for odontogenic tumors, ensuring accurate diagnosis and appropriate management.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Odontogenic Tumor Market

    Odontogenic tumor Market

     


    Latest Odontogenic tumor Companies Updates:


    Jan 2024


    Dentsply Sirona Launched their Orthophos SL 3D cone-beam CT scanner offering high-resolution imaging for precise diagnosis and treatment planning of odontogenic tumors.Partnered with a research institution to develop AI-powered software for automated odontogenic tumor identification and classification on CT scans.


    Straumann Group Introduced their BoneLevel Implant System designed for optimal bone integration and esthetic outcomes in post-tumor resection reconstruction procedures.Collaborated with leading oral pathologists to develop educational resources and clinical protocols for managing odontogenic tumors.


    Danaher Corporation Acquired a smaller company specializing in genetic testing for odontogenic tumors, expanding their diagnostic portfolio and personalized treatment options.Focused on research and development of targeted therapies for specific odontogenic tumor types based on their genetic signature.


    3D Systems Corporation Developed biocompatible 3D printing materials for custom-made surgical guides and implants, aiding in precise tumor resection and reconstruction.Partnered with medical centers to conduct clinical trials evaluating the efficacy and safety of 3D-printed solutions for odontogenic tumor management.


    Genea Biosciences Received FDA approval for their next-generation genetic test panel for identifying genetic mutations associated with aggressive odontogenic tumors, enabling early intervention and better prognosis.Collaborated with pharmaceutical companies to identify potential drug targets for personalized treatment of odontogenic tumors.


    List of Odontogenic tumor Key companies in the market



    • Midwest dental Inc,

    • Burkhart Dental Supply Co., Inc,

    • Delta Dental Plans Association,

    • Patterson Dental Supply, Inc,

    • DeCare Dental, LLC,

    • Oral Cancer Prevention International, Inc,

    • Zila, Inc,

    • Altima Dental Canada, Inc,

    • OraTec Corporation,

    • Oral health innovation Ltd,

    • Senior Dental Care, LLC,

    • Amerident Dental Inc